Precision Biosciences Stock Fundamentals
| DTIL Stock | USD 7.26 0.76 11.69% |
Precision BioSciences fundamentals help investors to digest information that contributes to Precision BioSciences' financial success or failures. It also enables traders to predict the movement of Precision Stock. The fundamental analysis module provides a way to measure Precision BioSciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Precision BioSciences stock.
At this time, Precision BioSciences' Net Interest Income is quite stable compared to the past year. Other Operating Expenses is expected to rise to about 110.6 M this year, although the value of Total Revenue will most likely fall to about 35.8 M. Precision | Select Account or Indicator |
Precision BioSciences Company Operating Margin Analysis
Precision BioSciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Precision BioSciences Operating Margin | (36.94) % |
Most of Precision BioSciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Precision BioSciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Precision Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Precision BioSciences has an Operating Margin of -36.9358%. This is 5.29% higher than that of the Biotechnology sector and 67.04% lower than that of the Health Care industry. The operating margin for all United States stocks is notably higher than that of the company.
Precision BioSciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Precision BioSciences's current stock value. Our valuation model uses many indicators to compare Precision BioSciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Precision BioSciences competition to find correlations between indicators driving Precision BioSciences's intrinsic value. More Info.Precision BioSciences is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . At this time, Precision BioSciences' Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Precision BioSciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Precision Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Precision BioSciences' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Precision BioSciences could also be used in its relative valuation, which is a method of valuing Precision BioSciences by comparing valuation metrics of similar companies.Precision BioSciences is currently under evaluation in operating margin category among its peers.
Precision BioSciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Precision BioSciences from analyzing Precision BioSciences' financial statements. These drivers represent accounts that assess Precision BioSciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Precision BioSciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 586.9M | 855.1M | 433.9M | 104.6M | 42.1M | 40.0M | |
| Enterprise Value | 524.1M | 751.9M | 354.7M | (57.9M) | (43.3M) | (41.2M) |
Precision BioSciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Precision BioSciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Precision BioSciences' managers, analysts, and investors.Environmental | Governance | Social |
Precision Fundamentals
| Return On Equity | 0.24 | ||||
| Return On Asset | -0.0638 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | (36.94) % | ||||
| Current Valuation | (15.2 M) | ||||
| Shares Outstanding | 7.67 M | ||||
| Shares Owned By Insiders | 6.50 % | ||||
| Shares Owned By Institutions | 44.70 % | ||||
| Number Of Shares Shorted | 214.55 K | ||||
| Price To Earning | (6.10) X | ||||
| Price To Book | 0.86 X | ||||
| Price To Sales | 0.74 X | ||||
| Revenue | 48.73 M | ||||
| Gross Profit | 25.1 M | ||||
| EBITDA | (32.04 M) | ||||
| Net Income | (61.32 M) | ||||
| Cash And Equivalents | 184.14 M | ||||
| Cash Per Share | 1.66 X | ||||
| Total Debt | 31.27 M | ||||
| Debt To Equity | 0.27 % | ||||
| Current Ratio | 4.59 X | ||||
| Book Value Per Share | 8.67 X | ||||
| Cash Flow From Operations | (84.11 M) | ||||
| Short Ratio | 2.57 X | ||||
| Earnings Per Share | 0.40 X | ||||
| Target Price | 35.75 | ||||
| Number Of Employees | 108 | ||||
| Beta | 1.69 | ||||
| Market Capitalization | 55.69 M | ||||
| Total Asset | 159.78 M | ||||
| Retained Earnings | (489.63 M) | ||||
| Working Capital | 86.37 M | ||||
| Current Asset | 174.05 M | ||||
| Current Liabilities | 23.86 M | ||||
| Net Asset | 159.78 M |
About Precision BioSciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Precision BioSciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Precision BioSciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Precision BioSciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 12 M | 22.1 M | |
| Total Revenue | 48.7 M | 35.8 M | |
| Cost Of Revenue | 8.3 M | 8.7 M | |
| Stock Based Compensation To Revenue | 0.29 | 0.28 | |
| Sales General And Administrative To Revenue | 0.80 | 1.25 | |
| Research And Ddevelopement To Revenue | 1.01 | 0.96 | |
| Capex To Revenue | 0.05 | 0.04 | |
| Revenue Per Share | 12.68 | 12.26 | |
| Ebit Per Revenue | (0.90) | (0.94) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Precision BioSciences Piotroski F Score and Precision BioSciences Altman Z Score analysis. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.4 | Revenue Per Share 12.872 | Quarterly Revenue Growth (0.96) | Return On Assets (0.06) | Return On Equity 0.2444 |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.